Vyome Holdings (HIND) Change in Inventory (2015 - 2025)
Vyome Holdings (HIND) posted quarterly Change in Inventory of $20000.0 for Q2 2025, up 131.25% year-over-year from $8648.6 in Q2 2024, and down 72.22% quarter-over-quarter from $72000.0 in Q1 2025.
Vyome Holdings (HIND) Change in Inventory (2015 - 2025) Analysis & Trends
Vyome Holdings' Change in Inventory history runs 11 years deep, the most recent figure standing at $20000.0 for Q2 2025.
- In Q2 2025, Change in Inventory rose 131.25% year-over-year to $20000.0; the TTM figure through Jun 2025 stood at -$446000.0 (down 224.93% YoY), while the FY2024 annual figure was -$922000.0, down 298.28% from the prior year.
- Change in Inventory for Q2 2025 stood at $20000.0, down from $72000.0 in the prior quarter.
- The five-year high for Change in Inventory was $1.1 million in Q1 2022, with the low at -$320000.0 in Q1 2024.
- The 5-year median for Change in Inventory is -$49500.0 (2022), against an average of $66166.7.
- The sharpest annual moves came in 2021 and 2024: Change in Inventory soared 1414.29% in 2021, then slumped 812.9% in 2024.
- Vyome Holdings' Change in Inventory stood at $390000.0 in 2021, then sank by 133.33% to -$130000.0 in 2022, then surged by 693.85% to $772000.0 in 2023, then plunged by 133.03% to -$255000.0 in 2024, then jumped by 107.84% to $20000.0 in 2025.
- Business Quant data shows HIND's Change in Inventory at $20000.0 in Q2 2025, $72000.0 in Q1 2025, and -$255000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Jun 30, 2024 | -64,000.00 |
| Jun 30, 2024 | -64,000.00 |
| Mar 31, 2024 | -320,000.00 |
| Mar 31, 2024 | -320,000.00 |
| Dec 31, 2023 | 772,000.00 |
| Dec 31, 2023 | 772,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | -168,000.00 |
| Jun 30, 2023 | -168,000.00 |
| Mar 31, 2023 | -108,000.00 |
| Mar 31, 2023 | -108,000.00 |